je.st
news
Tag: advanced
VJ Electronix to Show Advanced Rework Technologies at NEPCON South China
2015-07-27 12:31:13| Industrial Newsroom - All News for Today
VJ Electronix, Inc., the leader in rework technologies and global provider of advanced X-ray inspection systems, will exhibit in Booth A-1J35 at NEPCON South China, scheduled to take place Aug. 25-27, 2015 at the Shenzhen Convention Exhibition Center in China. VJ Electronix will highlight the new high-performance...
Tags: show
advanced
south
china
Freescale Semiconductor Helps Increase Passenger Safety With Advanced Automotive Radar Technology
2015-07-24 06:18:55| rfglobalnet Home Page
Building on their long-standing relationship, Freescale Semiconductor and Continental recently announced plans to integrate Freescale’s next 77 GHz radar technology into Continental’s next generation short- and mid-range automotive radar modules.
Tags: advanced
technology
increase
safety
Renesas Electronics Introduces 16- And 32-Megabit Advanced Low Power SRAMs With Over 500 Times The Resistance To Soft Errors Compared To Full CMOS Memory Cells
2015-07-23 05:15:25| electronicsweb Home Page
Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, recently announced the release of two new series of Advanced Low Power SRAM (Advanced LP SRAM), the leading type of low-power-consumption SRAM, designed to provide enhanced reliability and longer backup battery life for applications such as factory automation (FA), industrial equipment, and the smart grid
Advanced Power breaks ground on 700MW combined-cycle power facility in Ohio, US
2015-07-23 01:00:00| Power Technology
Swiss power developer Advanced Power's subsidiary Carroll County Energy has broken ground on the 700MW Carroll County Energy Facility in Ohio, US, together with US construction firm Bechtel.
Tags: us
advanced
power
ground
European Commission Approves Mercks Anti-PD-1 Therapy, KEYTRUDA (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma
2015-07-22 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYTRUDA Demonstrated Superior Survival versus Ipilimumab in a Phase 3 Clinical Trial KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the European Commission has approved KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, for the treatment of advanced (unresectable or metastatic) melanoma in adults. The European Commission approval of KEYTRUDA is based on data from three clinical studies conducted in more than 1,500 first-line and previously-treated patients with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orAn Phan, (908) 255-6325orInvestor:Joseph Romanelli, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: with
advanced
european
commission
Sites : [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] next »